Page 102 - AN-2-3

Advanced Neurology eGFR and serum neurofilament light chain

analysis of cohort studies. Am J Kidney Dis, 67: 89–97. 24. Beier D, Korsbæk JJ, Madsen JS, et al., 2020, Neurofilament
light chain as biomarker in idiopathic intracranial
https://doi.org/10.1053/j.ajkd.2015.08.027
hypertension. Cephalalgia, 40: 1346–1354.
19. Yu Z, Rebholz CM, Wong E, et al., 2019, Association
between hypertension and kidney function decline: The https://doi.org/10.1177/0333102420944866
atherosclerosis risk in communities (ARIC) study. Am J 25. Engel S, Halcour J, Ellwardt E, et al., 2023, Elevated
Kidney Dis, 74: 310–319. neurofilament light chain CSF/serum ratio indicates
impaired CSF outflow in idiopathic intracranial
https://doi.org/10.1053/j.ajkd.2019.02.015
hypertension. Fluids Barriers CNS, 20: 3.
20. Siller N, Kuhle J, Muthuraman M, et al., 2019, Serum
neurofilament light chain is a biomarker of acute and https://doi.org/10.1186/s12987-022-00403-2
chronic neuronal damage in early multiple sclerosis. Mult 26. Koini M, Pirpamer L, Hofer E, et al., 2021, Factors influencing
Scler, 25: 678–686. serum neurofilament light chain levels in normal aging.
Aging (Albany NY), 13: 25729–25738.
https://doi.org/10.1177/1352458518765666
https://doi.org/10.18632/aging.203790
21. Benkert P, Meier S, Schaedelin S, et al., 2022, Serum
neurofilament light chain for individual prognostication 27. Ciardullo S, Muraca E, Bianconi E, et al., 2023, Diabetes
of disease activity in people with multiple sclerosis: mellitus is associated with higher serum neurofilament light
A retrospective modelling and validation study. Lancet chain levels in the general US population. J Clin Endocrinol
Neurol, 21: 246–257. Metab, 108: 361–367.
https://doi.org/10.1016/S1474-4422(22)00009-6 https://doi.org/10.1210/clinem/dgac580
22. Bhat SA, Goel R, Shukla R, et al., 2017, Platelet CD40L induces 28. Maalmi H, Strom A, Petrera A, et al., 2023, Serum
activation of astrocytes and microglia in hypertension. Brain neurofilament light chain: A novel biomarker for early diabetic
Behav Immun, 59: 173–189. sensorimotor polyneuropathy. Diabetologia, 66: 579–589.
https://doi.org/10.1016/j.bbi.2016.09.021 https://doi.org/10.1007/s00125-022-05846-8
23. Rosenthal C, Wolf S, Weber-Carstens S, et al., 2012, 29. Kohlhase K, Frank F, Wilmes C, et al., 2023, Brain-specific
Intracranial hypertension-therapeutic options. Anasthesiol biomarkers in urine as a non-invasive approach to monitor
Intensivmed Notfallmed Schmerzther, 47: 30–38; quiz 39. neuronal and glial damage. Eur J Neurol, 30: 729–740.
https://doi.org/10.1055/s-0032-1301379 https://doi.org/10.1111/ene.15641

Volume 2 Issue 3 (2023) 9 https://doi.org/10.36922/an.1394